Latest Insider Transactions at Innov Age Holding Corp. (INNV)
This section provides a real-time view of insider transactions for Innov Age Holding Corp. (INNV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of InnovAge Holding Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of InnovAge Holding Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+21.25%
|
-
|
|
Jul 01
2025
|
Patricia Fontneau Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+28.95%
|
-
|
|
Jul 01
2025
|
Edward Moore Kennedy Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+27.08%
|
-
|
|
Jul 01
2025
|
Teresa Sparks Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+29.98%
|
-
|
|
Jul 01
2025
|
Marilyn B Tavenner Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+35.92%
|
-
|
|
Jul 01
2025
|
John Ellis Bush Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+35.92%
|
-
|
|
Jul 01
2025
|
James G Carlson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+22.47%
|
-
|
|
Jun 06
2025
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,056
-3.72%
|
$32,224
$4.02 P/Share
|
|
Jun 06
2025
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,088
-1.7%
|
$40,352
$4.02 P/Share
|
|
Jun 05
2025
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,880
-1.97%
|
$35,640
$3.97 P/Share
|
|
Jun 04
2025
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,046
-6.5%
|
$45,138
$3.96 P/Share
|
|
Jun 01
2025
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,323
-0.55%
|
$13,292
$4.09 P/Share
|
|
May 30
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
8,450
+10.98%
|
$33,800
$4.08 P/Share
|
|
May 29
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
14,265
+19.2%
|
$57,060
$4.04 P/Share
|
|
May 28
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
20,000
+30.4%
|
$80,000
$4.06 P/Share
|
|
May 23
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
1,198
+4.44%
|
$3,594
$3.93 P/Share
|
|
May 22
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
700
+2.77%
|
$2,800
$4.09 P/Share
|
|
May 21
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
1,147
+4.58%
|
$4,588
$4.13 P/Share
|
|
May 20
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
807
+3.43%
|
$3,228
$4.2 P/Share
|
|
May 16
2025
|
Richard C Zoretic Director |
BUY
Open market or private purchase
|
Direct |
2,086
+8.69%
|
$8,344
$4.28 P/Share
|
|
May 13
2025
|
Michael Anthony Scarbrough President and COO |
BUY
Open market or private purchase
|
Direct |
10,000
+23.26%
|
$30,000
$3.89 P/Share
|
|
May 12
2025
|
Michael Anthony Scarbrough President and COO |
BUY
Open market or private purchase
|
Direct |
13,000
+36.11%
|
$39,000
$3.73 P/Share
|
|
May 09
2025
|
Michael Anthony Scarbrough President and COO |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$30,000
$3.55 P/Share
|
|
Mar 01
2025
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,807
-0.62%
|
$11,421
$3.25 P/Share
|
|
Dec 01
2024
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-0.82%
|
$20,212
$4.87 P/Share
|
|
Nov 06
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,660
-0.71%
|
$9,960
$6.54 P/Share
|
|
Sep 17
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,521
-3.12%
|
$45,126
$6.0 P/Share
|
|
Sep 16
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,372
-1.78%
|
$21,860
$5.95 P/Share
|
|
Sep 05
2024
|
John Ellis Bush Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+50.0%
|
-
|
|
Sep 05
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+50.0%
|
-
|
|
Sep 05
2024
|
Edward Moore Kennedy Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+31.65%
|
-
|
|
Sep 05
2024
|
Marilyn B Tavenner Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+50.0%
|
-
|
|
Sep 03
2024
|
James G Carlson Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,495
+23.48%
|
-
|
|
Sep 03
2024
|
Patricia Fontneau Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,523
+37.96%
|
-
|
|
Sep 03
2024
|
Teresa Sparks Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,448
+32.73%
|
-
|
|
Sep 01
2024
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-0.81%
|
$30,318
$6.36 P/Share
|
|
Aug 15
2024
|
Richard Feifer CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,303
-6.08%
|
$85,818
$6.22 P/Share
|
|
Aug 15
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,303
-5.51%
|
$85,818
$6.22 P/Share
|
|
Jul 02
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,486
-2.8%
|
$37,430
$5.03 P/Share
|
|
Jun 06
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,056
-2.93%
|
$32,224
$4.83 P/Share
|
|
Jun 06
2024
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,088
-1.6%
|
$40,352
$4.83 P/Share
|
|
Jun 06
2024
|
Christine Bent CHIEF OPERATIONS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,187
-4.8%
|
$40,748
$4.83 P/Share
|
|
Jun 06
2024
|
Richard Feifer CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,023
-3.3%
|
$32,092
$4.83 P/Share
|
|
Jun 05
2024
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
123,967
+16.42%
|
-
|
|
Jun 04
2024
|
Christine Bent CHIEF OPERATIONS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
86,581
+28.98%
|
-
|
|
Jun 04
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
97,403
+26.15%
|
-
|
|
Jun 04
2024
|
Richard Feifer CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
108,226
+30.79%
|
-
|
|
Jun 01
2024
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,321
-0.65%
|
$13,284
$4.44 P/Share
|
|
Apr 17
2024
|
Christine Bent CHIEF OPERATIONS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,734
-6.5%
|
$34,936
$4.0 P/Share
|
|
Mar 01
2024
|
Patrick T Blair CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,566
-0.69%
|
$14,264
$4.87 P/Share
|